Jing Shi,1 Wei Zhang,2 Xiao Liu,1 Mingcheng Li3 

1Department of Dermatology, Jilin Central Hospital, Jilin, 132011, People’s Republic of China; 2Department of Clinical Laboratory, Jilin Central Hospital, Jilin, 132011, People’s Republic of China; 3Department of Clinical Microbiology, School of Laboratory Medicine, Beihua University, Jilin, Jilin, 132013, People’s Republic of China

Correspondence: Mingcheng Li, School of Laboratory Medicine, Beihua University, No. 3999 East Road of Binjiang, Jilin, Jilin, 132013, People’s Republic of China, Tel +86432-64608115, Email limingcheng@beihua.edu.cn Xiao Liu, Email yunxia_161@qq.com

Abstract: Sporotrichosis, a cutaneous or subcutaneous infection caused by the dimorphic fungus Sporothrix species, is widely distributed in China, with a notably higher incidence during colder seasons in northeastern Jilin Province. Recent advancements in Sporothrix taxonomy have significantly improved our understanding of diagnosis, epidemiology, and treatment strategies. In this review, we described the updated overview of recent progress of sporotrichosis, including etiology, epidemiology, clinical manifestations, diagnostic approaches, and treatment strategies, to provide a comprehensive description of preventive measures and control strategies aimed at facilitating future breakthroughs in research. We highlighted the geographical and population distributions specific to Jilin, China. The ongoing research efforts of novel diagnostic technologies, nanodrugs or nanoformulations treatment options are developed to advance knowledge about this sporotrichosis and its agents.

Keywords: sporotrichosis, sporothrix, treatment and prevention measures